Angiotensin-converting enzyme genotypes and risk for myocardial infarction in women

Journal of the American College of Cardiology

Volumn 31, Issue 4, 1998, Pages 790-796

  Anderson, Jeffrey L ^a,c   Carlquist, John F ^a   King, Gretchen J ^a   Morrison, Linda ^a   Thomson, Matthew J ^a   Ludwig, Erwin H ^a   Muhlestein, Joseph B ^a   Bair, Tami L ^a   Ward, Richard H ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c LDS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; DISEASE ASSOCIATION; ENZYME STRUCTURE; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE INSERTION; GENOTYPE; HEART INFARCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK ASSESSMENT;

AGED; ALLELES; DNA; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PEPTIDYL-DIPEPTIDASE A; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RISK FACTORS; SEX CHARACTERISTICS;

EID: 0032521257     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00007-2     Document Type: Article

References (41)

1. 1. Ehlers MRW, Riordan JF. Angiotensin converting enzyme: new concepts concerning its biological role. Biochemistry 1989;28:5311-8.
2. 2. Daeman MJAP, Lanbardi DM, Bosman FT, Schwartz SM. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res 1991;68:450-6.
3. 3. Gibbons GH, Pratt RE, Dzau VJ. Vascular smooth muscle cell hypertrophy vs hyperplasia: autocrine transforming factor-B1 expression determines growth response to angiotensin II. J Clin Invest 1992;90:456-61.
4. 4. Itoh H, Mukoyama M, Pratt RE, Gibbons GH, Dzau VJ. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J Clin Invest 1993;91:2268-74.
5. 5. Erdos EG. Angiotensin I-converting enzyme and the changes in our concepts through the years. Hypertension 1990;16:363-70.
6. 6. Hubert CD, Houot A-M, Corvol P, Soubrier F. Structure of the angiotensin I-converting enzyme gene. J Biol Chem 1991;266:1577-83.
7. 7. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/ deletion polymorphism of the human angiotensin I converting enzyme gene (DCPI). Nucleic Acids Res 1992;20:1433.
8. 8. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-6.
9. 9. Cambien F, Poirier O, Lecerf L, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992;359:641-3.
10. 10. Nakai K, Itoh C, Miura Y, et al. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation 1994;90:2199-2202.
11. 11. Ruiz J, Blanche H, Cohen N, et al. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 1994;91:3662-5.
12. 12. Leatham E, Barley J, Redwood S, et al. Angiotensin I-converting enzyme (ACE) polymorphism in patients presenting with myocardial infarction or unstable angina. J Hum Hypertens 1994;8:635-8.
13. 13. Ludwig E, Corneli PS, Anderson JL, Marshall HW, Lalouel J-M, Ward RH. Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation 1995;91:2120-4.
14. 14. Mattu RK, Needham EWA, Galten DJ, Frangos E, Clark AJL, Caulfield M. A DNA variant at the angiotensin-converting enzyme gene locus associates with coronary artery disease in the Caerphilly Heart study. Circulation 1995;91:270-4.
15. 15. Gardemann A, Weiss T, Schwartz O, et al. Gene polymorphism but not catalytic activity of angiotensin I-converting enzyme activity is associated with coronary artery disease and myocardial infarction in low-risk patients. Circulation 1995;92:2796-9.
16. 16. Bohn M, Berge KE, Bakken A, Erikssen J, Berg K. Insertion/deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme and parental history of myocardial infarction. Clin Genet 1993;44:298-301.
17. 17. Lindpaintner K, Pfeffer MA, Kreutz R, et al. A prospective evaluation of an angiotensin-converting enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995;332:706-11.
18. 18. Katsuya T, Koike G, Yee TW, et al. Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet 1995;345: 1600-3.
19. 19. Samani NJ, O'Toole L, Martin D, et al. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of and prognosis after myocardial infarction. J Am Coll Cardiol 1996;28:338-44.
20. 20. Singer DRJ, Missouris CG, Jeffery S. Angiotensin-converting enzyme gene polymorphism: what to do about all the confusion? Circulation 1996;94: 236-9.
21. 21. Samani NJ, Thompson JR, O'Toole L, Channer K, Woods KL. A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation 1996;94:708-12.
22. 22. Barrett-Connor E. Sex differences in coronary heart disease. Circulation 1997;95:257-64.
23. 23. Douglas PS. Coronary artery disease in women. In: Braunwald EB, editor. Heart Disease: A Textbook of Cardiovascular Medicine. 5th ed. Philadelphia: W.B. Saunders, 1997:1704-14.
24. 24. Marshall HW, Morrison LC, Wu LL, et al. Apolipoprotein polymorphisms fail to define risk of coronary artery disease. Circulation 1994;89:567-77.
25. 25. McClellan T, Jorde LB, Skolnick MH. Genetic distances between the Utah Mormons and related populations. Am J Hum Genet 1984;36:836-57.
26. 26. The Principal Investigators of CASS and their Associates. The National Heart, Lung, and Blood Institute Coronary Artery Surgery Study (CASS) [abstract]. Circulation 1981;63 Suppl I:I-81.
27. 27. Anderson JL, King GJ, Thomson MJ, et al. A mutation in the methylenetetrahydrofolate reductase gene is not associated with increased risk for coronary artery disease or myocardial infarction. J Am Coll Cardiol 1997; 30:1206-11.
28. 28. Shanmugan V, Sell K, Saha B. Mistyping ACE heterozygotes. PCR Methods Appl 1993;3:120-1.
29. 29. Carlquist JF, Ward RH, Meyer KJ, Husebye D, Feolo M, Anderson JL. Immune response factors in rheumatic heart disease: meta-analysis of HLA-DR associations and evaluation of additional class II alleles. J Am Coll Cardiol 1995;26:452-7.
30. 30. Tiret L, Kee F, Poirier O, et al. Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet 1993;341:1991-2.
31. 31. Reynolds MV, Bristow MR, Bush EW, et al. Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet 1993;342:1073-5.
32. 32. Schuster H, Wienker TF, Stremmler U, Noll B, Steinmetz A, Luft FC. An angiotensin-converting enzyme gene variant is associated with acute myocardial infarction in women but not in men. Am J Cardiol 1995;76:601-3.
33. 33. Haber E. Angiotensin-converting enzyme and lipoprotein(a) as risk factors in myocardial infarction. Circulation 1995;91:1888-90.
34. 34. Tiret L, Rigat B, Visvikis S, et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992;51:197-205.
35. 35. MacKenzie CA, Julier C, Forrester T, et al. Segregation and linkage analysis of serum angiotensin I-converting enzyme levels: evidence for two quantitative-trait loci. Am J Hum Genet 1995;57:1426-35.
36. 36. Jan Danser AH, Schalekamp MADH, Bax WA, et al. ACE in the human heart: effect of the deletion/insertion polymorphism. Circulation 1995;92: 1387-8.
37. 37. Powell JS, Clozel JP, Muller RKM. Inhibitors of angiotensin-converting enzyme myointimal proliferation after vascular injury. Science 1989;245: 186-8.
38. 38. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1992;327:669-77.
39. 39. Yusuf A, Pepine CJ, Garces C, et al. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet 1992;340:1173-8.
40. 40. Dakik HA, Mahmarian JJ, Verani MS, Farmer JA, Zhao G, Marian AJ. Association of angiotensin I-converting enzyme gene polymorphism with myocardial ischemia and patency of infarct-related artery in patients with acute myocardial infarction. J Am Coll Cardiol 1997;29:1468-73.
41. 41. Miletich MP, Prescott SM, White R, Majerus PW, Bovill EG. Inherited predisposition to thrombosis. Cell 1993;72:477-80.